Gonzalez-Perez, M.; Baranda, J.; Berges-Buxeda, M.J.; Conde, P.; Pérez-Olmeda, M.; Lozano-Ojalvo, D.; Cámara, C.; del Rosario Llópez-Carratalá, M.; Gonzalez-Parra, E.; Portolés, P.;
et al. Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination. Pharmaceuticals 2023, 16, 574.
https://doi.org/10.3390/ph16040574
AMA Style
Gonzalez-Perez M, Baranda J, Berges-Buxeda MJ, Conde P, Pérez-Olmeda M, Lozano-Ojalvo D, Cámara C, del Rosario Llópez-Carratalá M, Gonzalez-Parra E, Portolés P,
et al. Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination. Pharmaceuticals. 2023; 16(4):574.
https://doi.org/10.3390/ph16040574
Chicago/Turabian Style
Gonzalez-Perez, Maria, Jana Baranda, Marcos J. Berges-Buxeda, Patricia Conde, Mayte Pérez-Olmeda, Daniel Lozano-Ojalvo, Carmen Cámara, Maria del Rosario Llópez-Carratalá, Emilio Gonzalez-Parra, Pilar Portolés,
and et al. 2023. "Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination" Pharmaceuticals 16, no. 4: 574.
https://doi.org/10.3390/ph16040574
APA Style
Gonzalez-Perez, M., Baranda, J., Berges-Buxeda, M. J., Conde, P., Pérez-Olmeda, M., Lozano-Ojalvo, D., Cámara, C., del Rosario Llópez-Carratalá, M., Gonzalez-Parra, E., Portolés, P., Ortiz, A., Portoles, J., & Ochando, J.
(2023). Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination. Pharmaceuticals, 16(4), 574.
https://doi.org/10.3390/ph16040574
